medic suppli devic
risk ew tavr upsid impella
messag earn set kick high gear week launch
new product design leverag sku-level hospit purchas data help
investor better understand underli dynam across wide rang med-tech
product categori inaugur guggenheim mdi report examin purchas
data tavr hemodynam support market tell us
expect head result ew analysi suggest potenti
upsid come disappoint see possibl risk ew
take look insid hospit storeroom better understand underli dynam
across med-tech market med-tech data insight report leverag sku-level
purchas inform hospit cover dozen major
med-tech market backtest data find correl actual
compani result strongest identifi key product segment
insight use investor addit unit volum also make
use granular price product mix data paint complet pictur underli
dynam end market often possibl report revenu alon
today mdi report look purchas data tavr hemodynam support
market tell us potenti risk/upsid consensu estim
edward head compani quarterli result
start tavr modestli lower estim edward base
see possibl downsid risk street expect analysi volum
data june impli tavr sale yoy compar
current consensu forecast see figur base recent convers
investor believ expect may rise posit inflect tavr market
growth quarter wake impress low-risk data march view
continu low-risk adopt ramp gradual littl movement front
like late year earliest street model alreadi bake base case
scenario magnitud market acceler share perspect
gain sampl rel yet pick signific volum
sinc recent limit launch lotu edg valv meanwhil price
stabl roughli edward
lower ew tavr estim
impli yoy growth also tweak adjust ep forecast
penni full year expect ep total
revenu cc compar prior forecast
hemodynam support expect abiom bounc back disappoint
volum analysi impli impella sale compar
current street consensu get excit worth note
sampl would predict larger miss compani end
deliv result suspect inordin amount impella volum
site may slip march april physician got arm around fda
page analyst certif import disclosur
said dataset shown high correl report result
time view latest data point strong direct indic
abl bounc back recent stumbl mix
perspect rp account impella volum sampl consist
product recent trend fail indic shift away wake last
quarter controversi final overal asp across product portfolio held steadi
rais estim reflect increas confid
compani abil reacceler top line growth cours model
call sale includ impella revenu
compar current consensu estim
respect overal forecast adjust ep
sale respect
page analyst certif import disclosur
leader mechan circulatori support dedic enabl safer
treatment high-risk patient cardiovascular diseas recov injur heart
muscl estim patient receiv one compani famili impella
heart pump last year yet believ scratch surfac impella
long-term potenti estim market opportun includ
stemi see long runway growth level compani match
impella smallest heart pump world design provid temporari
hemodynam support patient undergo high-risk procedur whose cardiac
function compromis sinc impella first receiv approv
impella famili pump use support ten thousand peopl
abiom revenu grow compound-annual-growth-rate period go forward expect
ramp penetr protect pci cardiogen shock indic drive
continu strong growth compani still earli inning
capit intern opportun impella well recent guidelin
chang germani entri japanes market provid ampl momentum
go forward model call grow total revenu compound-annual-growth-rate
combin strong margin clean balanc sheet limit competit
view one best growth stori med-tech
share trade ntm revenu estim high end
multipl rang high-growth peer smid-cap med-tech group believ
abiom uniqu combin top line growth potenti compound-annual-growth-rate
profit gm om make compani difficult valu base
tradit metric result employ discount cash flow methodolog deriv
price target assum wacc termin growth rate
calcul forward npv per share target equat multipl
forward ntm sale estim signific potenti upsid price target
current level assign buy rate
downsid risk rate valuat includ potenti impella adopt
fall short street forecast pipelin setback clinic failur weaken abiom
long-term outlook faster-than-expect progress potenti impella competitor
premium valuat leav littl margin error view
page analyst certif import disclosur
edward one great med-tech success stori past decad
transform way valvular heart diseas treat process estim
world-wide tavr sale came cc edward busi
gener revenu cc work suggest tavr market
track reach sale next four year edward pois primari
beneficiari growth even competit increas howev street
expect acceler tavr market growth post low-risk label expans
alreadi high stock trade signific premium peer ntm ep vs
dont see risk/reward attract current level
edward share trade ntm ep estim ntm ebitda well
large-cap med-tech averag respect believ
edward best-in-class top-lin growth profil warrant premium valuat also make
compani difficult valu base tradit metric result employ
discount cash flow methodolog deriv fair valu estim assum
wacc termin growth rate calcul forward npv per
share equat multipl forward ntm ep estim
better upsid opportun elsewher group view remain neutral rate
upsid risk rate fair valu estim includ tavr market growth
exce street expect edward defend leadership posit world-wide
tavr share better forecast tmvr pipelin provid compani
meaning new growth driver sooner anticip
downsid risk rate fair valu estim includ tavr market growth
fall short street expect greater-than-expect share gain new tavr
competitor come market clinic and/or regulatori setback pipelin
program caus investor question sustain edward premium growth
page analyst certif import disclosur
issu research report guggenheim secur llc guggenheim secur research analyst whose name appear report
herebi certifi view express report accur reflect research analyst person view subject
secur issuer discuss herein ii part research analyst compens directli indirectli relat specif
recommend view express research analyst
research analyst research associ receiv compens base upon variou factor includ qualiti research investor client
feedback guggenheim secur llc overal revenu includ invest bank revenu
guggenheim secur llc affili expect receiv intend seek compens invest bank servic inc
corp next month
pleas refer websit company-specif disclosur referenc report http //guggenheimsecur bluematrix com/sellside/
disclosur action disclosur inform also avail complianc madison avenu new york ny
rate price target histori inc
creat bluematrix
rate price target histori corp ew
buy describ stock expect provid total return price appreci plu yield within period
neutral describ stock expect provid total return price appreci plu yield plu minu within
sell describ stock expect provid total neg return price appreci plu yield within period
creat bluematrix
page analyst certif import disclosur
